ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Beghin, Anne ^a,b   Belin, Stéphane ^c   Sleiman, Rouba Hage ^a,b   Manquat, Stéphanie Brunet ^a,b   Goddard, Sophie ^d   Tabone, Eric ^d   Jordheim, Lars P ^a,b   Treilleux, Isabelle ^d   Poupon, Marie France ^e   Diaz, Jean Jacques ^c   Dumontet, Charles ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

^d CENTRE LÉON BÉRARD   (France)

^e INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 2; PHOSPHOPROTEIN PHOSPHATASE 2A; SMALL INTERFERING RNA; ARL2 PROTEIN, MOUSE; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CELL DEATH; CELL PROLIFERATION; CLONOGENESIS; CONTACT INHIBITION; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TUMOR VOLUME; ANIMAL; BREAST TUMOR; CANCER INVASION; GENE EXPRESSION REGULATION; LYMPH NODE METASTASIS; METABOLISM; MOUSE MUTANT; PHENOTYPE; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

MUS;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HUMANS; LYMPHATIC METASTASIS; MICE; MICE, SCID; NEOPLASM INVASIVENESS; PHENOTYPE; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70449365837     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007478     Document Type: Article

References (29)

1. Kahn RA, Kern FG, Clark J, Gelmann EP, Rulka C (1991) Human ADP-ribosylation factors. A functionally conserved family of GTP-binding proteins. J Biol Chem 266: 2606-2614.
2. Kahn RA, Volpicelli-Daley L, Bowzard B, Shrivastava-Ranjan P, Li Y, et al. (2005) Arf family GTPases: roles in membrane traffic and microtubule dynamics. Biochem Soc Trans 33: 1269-1272.
3. Antoshechkin I, Han M (2002) The C. elegans evl-20 gene is a homolog of the small GTPase ARL2 and regulates cytoskeleton dynamics during cytokinesis and morphogenesis. Dev Cell 2: 579-591.
4. Hoyt MA, Macke JP, Roberts BT, Geiser JR (1997) Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability. Genetics 146: 849-857.
5. Radcliffe PA, Vardy L, Toda T (2000) A conserved small GTP-binding protein Alp41 is essential for the cofactor-dependent biogenesis of microtubules in fission yeast. FEBS Lett 468: 84-88.
6. Bhamidipati A, Lewis SA, Cowan NJ (2000) ADP ribosylation factor-like protein 2 (Arl2) regulates the interaction of tubulin-folding cofactor D with native tubulin. J Cell Biol 149: 1087-1096.
7. Lopez-Fanarraga M, Avila J, Guasch A, Coll M, Zabala JC (2001) Review: postchaperonin tubulin folding cofactors and their role in microtubule dynamics. J Struct Biol 135: 219-229.
8. Tian G, Bhamidipati A, Cowan NJ, Lewis SA (1999) Tubulin folding cofactors as GTPase-activating proteins. GTP hydrolysis and the assembly of the alpha/ beta-tubulin heterodimer. J Biol Chem 274: 24054-24058.
9. Tian G, Lewis SA, Feierbach B, Stearns T, Rommelaere H, et al. (1997) Tubulin subunits exist in an activated conformational state generated and maintained by protein cofactors. J Cell Biol 138: 821-832.
10. Tian G, Vainberg IE, Tap WD, Lewis SA, Cowan NJ (1995) Quasi-native chaperonin-bound intermediates in facilitated protein folding. J Biol Chem 270: 23910-23913.
11. Shultz T, Shmuel M, Hyman T, Altschuler Y (2007) {beta}-tubulin cofactor D and ARL2 take part in apical junctional complex disassembly and abrogate epithelial structure. Faseb J.
12. Shern JF, Sharer JD, Pallas DC, Bartolini F, Cowan NJ, et al. (2003) Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2A. J Biol Chem 278: 40829-40836.
13. Minshull J, Straight A, Rudner AD, Dernburg AF, Belmont A, et al. (1996) Protein phosphatase 2A regulates MPF activity and sister chromatid cohesion in budding yeast. Curr Biol 6: 1609-1620.
14. Janssens V, Goris J, Van Hoof C (2005) PP2A: the expected tumor suppressor. Curr Opin Genet Dev 15: 34-41.
15. Van Hoof C, Goris J (2003) Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question. Biochim Biophys Acta 1640: 97-104.
16. Calin GA, di Iasio MG, Caprini E, Vorechovsky I, Natali PG, et al. (2000) Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 19: 1191-1195.
17. Wang SS, Esplin ED, Li JL, Huang L, Gazdar A, et al. (1998) Alterations of the PPP2R1B gene in human lung and colon cancer. Science 282: 284-287.
18. Fujiki H, Suganuma M (1993) Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv Cancer Res 61: 143-194.
19. Gehringer MM (2004) Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response. FEBS Lett 557: 1-8.
20. Beghin A, Honore S, Messana C, Matera EL, Aim J, et al. (2007) ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells. Exp Cell Res 313: 473-485.
21. Beghin A, Matera EL, Brunet-Manquat S, Dumontet C (2008) Expression of Arl2 is associated with p53 localization and chemosensitivity in a breast cancer cell line. Cell Cycle 7: 3074-3082.
22. Lao DH, Yusoff P, Chandramouli S, Philp RJ, Fong CW, et al. (2007) Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation. J Biol Chem 282: 9117-9126.
23. Neviani P, Santhanam R, Trotta R, Notari M, Blaser BW, et al. (2005) The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein. Cancer Cell 8: 355-368.
24. Messner DJ, Romeo C, Boynton A, Rossie S (2006) Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells. J Cell Biochem.
25. Stehbens SJ, Paterson AD, Crampton MS, Shewan AM, Ferguson C, et al. (2006) Dynamic microtubules regulate the local concentration of E-cadherin at cell-cell contacts. J Cell Sci 119: 1801-1811.
26. Takahashi K, Nakajima E, Suzuki K (2006) Involvement of protein phosphatase 2A in the maintenance of E-cadherin-mediated cell-cell adhesion through recruitment of IQGAP1. J Cell Physiol 206: 814-820.
27. Jordheim LP, Cros E, Gouy MH, Galmarini CM, Peyrottes S, et al. (2004) Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug. Clin Cancer Res 10: 5614-5621.
28. Debnath J, Muthuswamy SK, Brugge JS (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268.
29. Bode CJ, Gupta ML, Suprenant KA, Himes RH (2003) The two alpha-tubulin isotypes in budding yeast have opposing effects on microtubule dynamics in vitro. EMBO Rep 4: 94-99.